ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

January 10, 2014

Obese Men With Benign Biopsy At High Risk for Prostate Cancer

April 26, 2013

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

NCI CTEP-Approved Trials For the Month of August

August 29, 2014

Contracts Cutback Canceled 7 RFPs

August 8, 1980

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 12, 1990